accountalong with a hike of EPS estimates. This morning, Goldman Sachs raised its price target on shares of Cardinal Health to $40 as the company's recent acquisition is expected be accretive to earnings. With the higher price target, Goldman also raised its...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Goldman Flies Cardinal To New $40 Target
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account